Meier and coauthors found that topotecan improved progression-free and overall survival compared with treosulfan in patients with recurrent ovarian cancer following platinum and taxane-based therapy.

Patients who have relapsed or individuals who do not respond to first-line chemotherapy can be treated with topotecan. Phase II and III studies have confirmed the efficacy of topotecan as second ...

Get detailed information on Topotecan, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

The FDA granted elraglusib a rare pediatric disease designation for Ewing sarcoma based on findings from the 1/2 Actuate-1902 ...